Clinical Trial

Exercise in Hereditary ATTR (ATTRv) Amyloidosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 24, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the effects of a 12-week exercise intervention on the physical and mental health of people living with Hereditary ATTR (ATTRv) Amyloidosis, a rare genetic disease caused by mutations in the transthyretin gene, leading to the deposition of amyloid fibrils in nerves and organs.
Trial Details
NCT Number NCT07033715
Lead Sponsor University of Maia
Conditions Amyloidosis, Hereditary, Transthyretin-Related
Enrollment 42 participants
Start Date 2024-10-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-24